News for Bruker Corporation (BRKR)

September S&P 500 E-Mini futures (ESU25) are trending down -0.04% this morning as investors brace for a raft of corporate earnings reports and continue to keep a close eye on any trade developments between the U.S. and key trading partners as the August 1st deadline approaches.

Shares of Bruker Corporation, identified by the ticker BRKR, experienced a significant decline, falling 14.5% or $5.88, bringing the price down to $34.67. The d

[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million

Key Highlights: Bruker (BRKR) reports preliminary Q2 revenue below expectations, triggering a share drop. Analysts remain optimistic with average price t

Bruker Corporation (BRKR) expects second quarter 2025 revenues between $795-$798 million. Non-GAAP organic revenue declined approximately 7% year-over-y

S&P 500 record high headlines Fridays market rally as U.S. stocks soared on renewed trade deal hopes between President Donald Trump and China. The S&P 500 rose 0.4% to close at 6,168.60, topping its previous high from February. The Nasdaq Composite also hit a new record, while the Dow Jones gained 156 points. Investors were lifted by news of a finalized trade framework with China and talks with 10 more nations. AI stocks like Nvidia and Microsoft led the charge. Despite inflation rising slightly, markets stayed upbeat on expected Federal Reserve rate cuts and cooling global tensions.

US Stock futures rise as hopes for a U.S.-China trade deal lift investor sentiment, pushing the S&P 500 close to its all-time high. President Donald Trump confirmed a new trade framework with China, while Commerce Secretary Howard Lutnick revealed similar deals with 10 key partners are underway. Markets reacted positively, with S&P 500 futures up 0.3% and Nasdaq-100 gaining 0.4%. Rare earth exports and tech restrictions from China are easing, while investors eye U.S. inflation data today. This combination of trade optimism, easing tensions, and strong rebound sets the tone for a potentially record-breaking day on Wall Street.

Brown Brothers Harriman & Co., a global financial services firm, released its “The BBH Select Series – Mid Cap Fund” first quarter investor letter. A copy of the same can be downloaded here.

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best Canadian stocks with huge upside potential. Earlier in May, AbCellera Biologics announced that the US Court of Appeals for the Federal Circuit/CAFC issued a Rule 36 Order, which affirmed the validity of its US Patent No. 10,087,408 (“the ‘408 Patent”). The patent specifically covers microfluidic devices […]

10x Genomics, Inc. (NASDAQ:TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has announced a global settlement agreement with Bruker Corporation, which resolves all outstanding patent litigation between the two firms. As per the agreement, from Q3 2025 to Q2 2026, Bruker will pay 10x Genomics, Inc. (NASDAQ:TXG) $68 […]

Bruker Corporation (NASDAQ:BRKR) announced the acquisition of Biocrates Life Sciences AG, a prominent Austrian company specialized in quantitative metabolomics.

Market Performance Overview The stock market gained momentum today, maintaining its upward trend despite Elon Musk's criticism of a budget bill, which he clai

Bruker Corporation (BRKR) showcases innovations at ASMS 2025, including the new timsMetaboâ„¢ platform for small molecule analysis. Integration with REC

Key Takeaways: Bruker Corporation's strategic acquisition of biocrates life sciences ag enhances its position in the multiomics market. Analysts project

Bruker Corporation (BRKR) has announced a major enhancement in the field of ultra-high sensitivity 4D-Proteomics through the release of its latest innovation, t

During the 73rd Conference on Mass Spectrometry and Allied Topics, Bruker Corporation introduced its latest innovation, the proteoElute nanoLC system. This new

Bruker Corporation (BRKR) has launched the new timsUltra AIP system, promising groundbreaking sensitivity for single-cell proteomics and metaproteomics.

[url="]Bruker Corporation[/url] (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New

Bruker Corporation (BRKR) will present at the Jefferies Global Healthcare Conference on June 4, 2025, in New York City. A live audio webcast of the pres